MO57-3 Effect of immunochemotherapy time-of-day infusion, sequence and interval on prognosis of advanced esophageal cancer
Shengyun Huang(Chinese University of Hong Kong), G. Qiao(Guangdong Academy of Medical Sciences), Pei Tang(State Key Laboratory of Vehicle NVH and Safety Technology), Liping Xie(First Affiliated Hospital Zhejiang University), Xiaosong Ben(Guangdong Academy of Medical Sciences), Y. Tang(Guangdong Academy of Medical Sciences), Jie Tang(Bengbu Medical College), Gong Chen(Guangdong Pharmaceutical University), Rong Chen(Guangdong Academy of Medical Sciences), Jianguo Sun(Army Medical University), Haiying Wu(Shantou University), Haixia Zhou(Soochow University), Zhihui Gao(Nankai University), Shuai Wang(Southwest University), Zhuolan Li(Guangdong Academy of Medical Sciences), Jun Liu(Wenzhou University), Dong Zhang(Fudan University)
Cited by 0
Related Papers
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
|Science|2007|696
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
The ubiquitin-specific protease USP28 is required for MYC stability
|Nature Cell Biology|2007|491